Diagnosis
Noninvasive high-grade papillary urothelial carcinoma. Chronic inactive glandular urethritis. Status post three courses of chemotherapy.
Patient:
Male, 59 years old, Ukraine
Physician:
Chief Physician of the Urology Department at the Klinikum Dortmund, Professor Michael Truss
Response from the urologist and surgeon, Prof. Michael Truss
Based on the information provided, we are dealing with tumor progression after standard neoadjuvant chemotherapy. In this situation, a cystoprostatectomy is required, followed by the creation of a urinary diversion reservoir (neobladder).
Patient Questions
- Does this mean that surgery is the most effective treatment option in this case?
- How many such operations have you performed or currently perform?
- How long is the hospital stay?
Physician’s Answers
- Overall, the situation is very complex. Considering the patient’s age, the general prognosis, and tumor control, I believe that within the framework of multimodal therapy, surgery is the best option. After surgery, adjuvant chemotherapy would be advisable.
- We perform such operations on average once a week. Over the past years, we have carried out several hundred of these procedures.
- The approximate duration of inpatient treatment is 18 days.
Estimated treatment cost: 27,850 EUR